Nanoparticles retard immune cells recruitment in vivo by inhibiting chemokine expression

Jianxiong Xu,Jinxuan Wang,Juhui Qiu,Hua Liu,Yi Wang,Yuliang Cui,Rose Humphry,Nan Wang,Colm DurKan,Yaokai Chen,Yanqiu Lu,Qinfeng Ma,Wei Wu,Yang Luo,Lehui Xiao,Guixue Wang
DOI: https://doi.org/10.1016/j.biomaterials.2020.120392
IF: 14
2021-01-01
Biomaterials
Abstract:<p>The large-scale utilization of nanotechnology depends on public and consumer confidence in the safety of this new technology. Studying the interaction of nanoparticles with immune cells plays a vital role in the safety assessment of nanomedicine. Although some researches have indicated that the immune cells undergo severe interfere after phagocytosis of nanoparticles, the impact on immune system of the whole body are still unclear. Here, we use immune cells labeled transgenic zebrafish to study the mechanisms of nanoparticles on zebrafish immune cells. We demonstrate that gold nanoparticles (Au NPs) phagocytized by immune cells can reduce and retard the sensitivity of immune response, resulting nanoparticle-induced bluntness in immune cell (NIBIC). RNA-seq and functional analysis reveal that NIBIC is mainly induced by the inhibiting expression of chemokine receptor 5 (CCR5). Furthermore, PVP-modified Au NPs can eliminate NIBIC by inhibiting the cell phagocytosis. Our results highlight the potential risk for Au NPs <em>in vivo</em> and further the understanding of the mechanism of the interaction between Au NPs and the immune response. We should consider this factor in future material design and pay more attention to the process of using nanomedicines on immune diseases.</p>
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: **What impact do nanoparticles (NPs) have on the recruitment process of immune cells in vivo? In particular, do they slow down or prevent the recruitment of immune cells by inhibiting the expression of chemokines?** Specifically, the researchers focused on how gold nanoparticles (Au NPs) affect the function of immune cells. They found that when immune cells phagocytosed Au NPs, the sensitivity of these cells to external stimuli decreased, resulting in a reduced aggregation of them at the injury site. This phenomenon was named "nanoparticle - induced immune cell sluggishness" (NIBIC). In addition, the study also revealed that Au NPs can affect the migration and retention of macrophages by down - regulating the expression of chemokine receptor 5 (CCR5). To verify whether this phenomenon is普遍存在 in different types of nanoparticles, the researchers also tested nanoparticles of different sizes and compositions (such as 70 nm Au NPs, 140 nm Au NPs, PLGA NPs and SiO₂ NPs), and found that these nanoparticles also exhibited a similar inhibitory effect on immune cell recruitment. In summary, this study aims to explore the potential impact of nanoparticles on the immune system and reveal the underlying molecular mechanisms, providing an important reference for the future design and application of nanomaterials.